Serotonin receptors in depression and anxiety: Insights from animal studies

Life Sci. 2018 Oct 1:210:106-124. doi: 10.1016/j.lfs.2018.08.050. Epub 2018 Aug 23.

Abstract

Serotonin regulates many physiological processes including sleep, appetite, and mood. Thus, serotonergic system is an important target in the treatment of psychiatric disorders, such as major depression and anxiety. This natural neurotransmitter interacts with 7 families of its receptors (5-HT1-7), which cause a variety of pharmacological effects. Using genetically modified animals and selective or preferential agonists and antagonist, numerous studies demonstrated the involvement of almost all serotonin receptor subtypes in antidepressant- or anxiolytic-like effects. In this review, based on animal studies, we discuss the possible involvement of serotonin receptor subtypes in depression and anxiety.

Keywords: Animal studies; Antidepressant-like; Anxiolytic-like; Serotonin; Serotonin receptors.

Publication types

  • Review

MeSH terms

  • Animals
  • Anxiety Disorders / metabolism
  • Anxiety Disorders / physiopathology*
  • Behavior, Animal
  • Depressive Disorder / metabolism
  • Depressive Disorder / physiopathology*
  • Disease Models, Animal*
  • Receptors, Serotonin / metabolism*

Substances

  • Receptors, Serotonin